Supplying sodium valproate safely to women and girls

25 July 2019

All members of the pharmacy team should make sure they follow the MHRA’s Pregnancy Prevention Programme (PPP) for sodium valproate every time it is dispensed. 

We spoke to two women whose children were affected by exposure to sodium valproate during their pregnancies, to find out why it’s so important to make sure that women are made aware of the risks when dispensing sodium valproate.

See the previous Regulate article on dispensing sodium valproate safely
 

Related articles

4 October 2022
In this article Aileen O’Hare, one of our specialist inspectors, shares examples of good clinical governance in an online pharmacy setting, which have been identified through our inspection work....
4 October 2022
With a growing demand for online pharmacy services, models of delivery are developing rapidly - which means pharmacy and other healthcare services are being delivered in new and innovative ways. This...
31 May 2022
The next time you renew on or after 1 October 2022, you’ll need to complete a full revalidation submission: four CPD records, a peer discussion and a reflective account. Here’s a quick guide to what...
31 May 2022
Specialist inspectors have identified cases of Salbutamol inhaler overprescribing of up to six inhalers per prescription by online prescribers. In this article, co-produced by our CPhO Clinical...
31 May 2022
Instead of pharmacists needing to be on the register for two years before applying for an independent prescriber course, applicants will need to have relevant experience in a pharmacy setting and be...